rebecca sutherland

ID consultant

[Eric Macy @EricMacyMD]

An important lesson here. Anaphylaxis occurred with systemic exposure to only about 0.5 mg of ampicillin. ID skin testing (0.02ml) using ampicillin 25 mg/ml.

Use 0.01 molar for beta-lactams.

Fatal ampicillin-sulbactam anaphylaxis in a 34-year-old male
https://t.co/bpVehrnknk

[Cliff Reid @cliffreid]

If anyone knows Kirsty the internal medicine trainee/recent geriatrics clinical fellow from Edinburgh who recently managed an in-flight emergency from Sydney to Hong Kong please tell her she’s awesome & pass on my thanks & Twitter contact so I can give her patient follow up info

[Steve Mathieu @stevemathieu75]

A difficult story to read ⤵️

Intensive Care is an incredibly rewarding but sometimes gruelling specialty even in ‘normal’ times. The psychological impact of the pandemic on health care professionals must not be underestimated @ICS_updates @SteveBarclay

https://t.co/L4Ym7uCWEA

[Oxford Students Liberal Association @OxUniLibDems]

sorry

[Oliver Koch @okoch]

HCID preparedness planning & PPE training @ridu_nhsl. Expertly facilitated by @CallumPMutch & @BRPoller & @NHSLothianMedEd. @WghLothian @NHS_Lothian

[Nazir Lone @ICULone]

Our 9th #sicsag #covid19 report on Scottish ICUs highlighting unvaccinated 6x more likely to be admitted to ICU, more than 28% of ICUs unable to meet recommended staffing levels, and information on 75 pregnant/recently pregnant women with covid19
https://t.co/uWMbZXw6G9

[rebecca sutherland @rksutherland]

A book all doctors and patients should read.. wise and eloquent (as always).

[Stephanie Dundas @DundasSteph]

#rcpeStAs21 compassionate governance much more effective than route cause analysis

[CIRG Edinburgh @CIRGedinburgh]

Hi. Hello. Awrite. 👋

We're CIRG - Lothian's Clinical Infection Research Group.

We've got a BRAND NEW WEBSITE. Check it out to find out what we're all about ⬇️⬇️⬇️
https://t.co/wFhDFfnMtk

[University of Oxford @UniofOxford]

Prof Sir Andy Pollard,'We pay tribute to the superhuman efforts of the teams at @AstraZeneca @SerumInstIndia and at sites around the world in producing a phenomenal number of doses 24 hrs a day & getting them to vaccine clinics in more than 170 countries.'

[Cynthia Nguyen @cynth_ID]

Pretty cool - we de-labeled 14 (7%) patients with just an interview! No graded challenges, no penicillin skin testing. Feels so good to delete allergies from the EHR. 😎

[rebecca sutherland @rksutherland]

… ‘there is a bigger issue, our responsibility to humanity’

[Toni Campanella @toni_pharmd]

“Infectious diseases might actually know what’s going on” 😂 #IDtwitter

[Andrew Pollard @ajpollard1]

A milestone today 200 million doses to 172 countries @OxfordVacGroup @AstraZeneca @JennerInstitute with 100 countries reached by #covax @WHO and thousands of lives saved in uk alone https://t.co/BSfDXTf1HI

[Infectious Disease News @InfectDisNews]

#ICYMI: A 4-month daily regimen of rifapentine and moxifloxacin was noninferior to the standard 6-month regimen for tuberculosis treatment among people with HIV enrolled in a phase 3 clinical trial, researchers reported at #CROI2021.
https://t.co/5woeQ0tthG

[JennerVaccineTrials @VaccineTrials]

New study shows that the #OxfordVaccine offers protection of 76% up to 12 weeks after a single dose, with further data supporting a 4-12 week dosing interval.

https://t.co/izahNjiJuk

#COVID19 #Oxford

[Graham Cooke @grahamscooke]

A huge thank you to over 2 million people across the UK consenting to COVID related studies this year (covering vaccines, diagnostics, treatments and more). Your contributions have been critical to our understanding of this new disease and I hope you can recommend the experience.

[rebecca sutherland @rksutherland]

@MinaGagaP Thank you Mina x

[Government Office for Science @uksciencechief]

“Great news the @UniofOxford @AstraZeneca
vaccine has been approved. Huge congratulations and thanks to everyone involved - from scientists to engineers to doctors, nurses and patients in the trials. Now let’s get as many people vaccinated as we can through our fantastic NHS”-PV

[JennerVaccineTrials @VaccineTrials]

We are delighted to have received an approval from the MHRA for the use of our ChAdOx1 nCoV-19 vaccine in the UK - a major step towards the end of the COVID-19 pandemic.
#COVID19 #CovidVaccine @UniofOxford